Sx
Hoarseness
search
Hoarseness
, Laryngitis
See Also
Acute Laryngitis
Chronic Laryngitis
Epidemiology
Hoarseness is common, with a point
Prevalence
as high as 7% for those <65 years old
Pathophysiology
Abnormal voice production (change in pitch, loudness or effort)
Breathiness
Harsh, rough or raspy voice
Lack of smooth vocal cord approximation
Laryngeal pathology
Abnormal vocal cord mobility
Usually caused by organic disorder (not functional)
Causes
See
Hoarseness Causes
Symptoms
Abnormal voice quality (e.g. Breathy, Strained, Raspy, Weak)
History
See
Hoarseness History
Evaluation
Laryngoscopy
Indications (see
Laryngeal Exam
ination)
More than 4 weeks of Hoarseness despite specific management trials (see below)
More than 2 weeks of symptoms and risk factors for
Laryngeal Cancer
Tobacco Abuse
Alcohol Abuse
Gastroesophageal Reflux
disease (esp. if longstanding or with
Dysphagia
)
Hemoptysis
Management
Suspect benign causes (esp. in first 2 weeks of symptoms)
See
Acute Laryngitis
See
Chronic Laryngitis
Consider
Laryngoscopy
if Hoarseness persists despite empiric management
Gene
ral measures: Vocal Hygiene
Voice rest (do not whisper!)
Avoid
Tobacco
,
Alcohol
and other irritants
Consider humidifier
Avoid raising voice volume
Upper Respiratory Infection
, allergy, or
Voice Abuse
Voice rest and symptomatic treatment
Gastroesophageal Reflux
symptoms (suggests
Reflux Laryngitis
)
Trial on
Proton Pump Inhibitor
(expect improvement by 4 weeks)
Inhaled Corticosteroid
use
Use spacer with
Inhaler
Gargle and rinse mouth (or drink water after)
If using Fluticasone, Budesonide or Beclomethasone, consider substituting other
Inhaled Corticosteroid
Consider reducing or trialing off
Inhaled Corticosteroid
(expect improvement in 4 weeks)
Underlying systemic or neuromuscular condition (e.g.
Hypothyroidism
,
Parkinsonism
)
Treat the underlying cause
Voice therapy indications (
Behavior Modification
training in 30-60 min weekly sessions for 8-10 weeks)
Significantly vocal dysfunction
Nonorganic
Dysphonia
Benign
Vocal Fold Lesion
s
Age-related vocal atrophy
Preventive
Vocalist, singer or public speaker
Management
Temporary voice restoration prior to performance
Indications
Professional singer or speaker and
Vocal fold edema present by
Nasolaryngoscopy
Contraindications
Vocal fold
Hemorrhage
, abrasion by
Nasolaryngoscopy
Preparations (not FDA approved)
Voice rest is preferred
Results in faster healing time
Prednisone
40 mg PO given 4 hours prior to event
Corticosteroid
s do not decrease healing time
Not generally recommended
Afrin
sprayed directly on
Larynx
References
Woodson in Rakel (2003) Conn's Therapy, p. 210
Postma in Cummings (1998) Otolaryngology, p. 2064
References
Dworkin (2008) Otolaryngol Clin North Am 41(2):419-36 [PubMed]
Feierabend (2009) Am Fam Physician 80(4): 363-70 [PubMed]
House (2017) Am Fam Physician 96(11): 720-8 [PubMed]
Type your search phrase here